Skip to main content


Figure 3 | BMC Cancer

Figure 3

From: Recurrence and mortality according to Estrogen Receptor status for breast cancer patients undergoing conservative surgery. Ipsilateral breast tumour recurrence dynamics provides clues for tumour biology within the residual breast

Figure 3

Hazard rate estimates for distant metastasis in 1615 ERP tumours 427 ERN tumours from patients undergoing conservative surgery (quadrantectomy or tumourectomy) plus RT. These data show that the recurrence peak timing after conservative resection is maintained regardless of tumour hormonal receptor status. Patients with ERN tumours do worse during early years and better later. Vertical lines represent point-wise confidence interval for the model estimated hazards, according to standard asymptotic theory.

Back to article page